share_log

盘中速览 | 港股三大指数集体涨超1%;黄金、生物医药板块走强,宜明昂科大涨超50%

Intraday overview | Hong Kong's three major indices collectively rose more than 1%; gold and biomedical sectors were strong, and Yiming Angkedao rose more than 50%.

Futu News ·  Sep 13 11:37

Futu news on September 13th, the major Hong Kong stock indices are all up, at the time of publication, $Hang Seng Index (800000.HK)$ up 1.48%, $Hang Seng China Enterprises Index (800100.HK)$ up 1.52%, $Hang Seng TECH Index (800700.HK)$ up 1.25%.

In terms of sectors, network technology stocks have collectively risen, with Sensetime up nearly 3%, Meituan up over 2%, Xiaomi, Alibaba, Baidu up over 1%, Tencent, JD.com up nearly 1%.

Golden industrial concept collectively rises, SD Gold rises nearly 6%, Zhaojin Mining rises more than 5%, Zijin Mining Group rises more than 4%.

Mainland real estate strengthens, Midea Real Estate rises more than 6%, China Jinmao, China Res Land, Longfor Group rise more than 4%.

Petroleum stocks rise, the 'Big Three' oil companies all rise, PetroChina rises nearly 2%, Sinopec Corp rises nearly 4%, CNOOC rises nearly 3%.

Biotechnology sector continues to rise, Junshi Biosciences rises more than 50%, Akeso rises more than 5%, Wuxi AppTec rises nearly 5%, Genscript Bio rises more than 4%.

Most bank stocks rise, CM Bank rises nearly 3%, Bank of Qingdao rises more than 2%, Postal Savings Bank of China rises 2%.

As for individual stocks,$WUXI APPTEC (02359.HK)$ Rises nearly 5% again, plans to spend 1 billion yuan to buy back shares, management said the short-term impact of the US bill is controllable.

$CHINA RES LAND (01109.HK)$ It rose by nearly 5%, with regular income in August of about 4 billion yuan, an increase of 12.2% year-on-year.

$IMMUNEONCO-B (01541.HK)$ It surged by over 50%, recently received further payments from the American partner SynBioTx for IMM2510, etc., and will receive a maximum payment of 35 million US dollars in the future.

Editor / jayden

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment